Research Article
P M Chavassieux, M E Arlot, C Reda, L Wei, A J Yates, P J Meunier
Title and authors | Publication | Year |
---|---|---|
Development of a Medication-Related Osteonecrosis of the Jaw Prediction Model Using the FDA Adverse Event Reporting System Database and Machine Learning
Toriumi S, Shimokawa K, Yamamoto M, Uesawa Y |
Pharmaceuticals | 2025 |
Mild antiresorptive activity of an anti-vascular endothelial growth factor A antibody and sunitinib in a rat model of bone resorption
Aguirre JI, Croft SM, Castillo EJ, Cruz-Camacho CJ, Kimmel DB |
Bone Reports | 2025 |
Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy
Qiu S, Dhaliwal R, Divine G, Warner E, Rao SD |
Journal of Bone and Mineral Research | 2024 |
Clinical Data for Parametrization of In Silico Bone Models Incorporating Cell-Cytokine Dynamics: A Systematic Review of Literature.
Ledoux C, Boaretti D, Sachan A, Müller R, Collins CJ |
Frontiers in Bioengineering and Biotechnology | 2022 |
Added effect of 1% topical alendronate in intra-bony and inter-radicular defects as part of step II periodontal therapy: a systematic review with meta-analysis and trial sequential analysis.
Arena C, Caponio VCA, Zhurakivska K, Lo Russo L, Lo Muzio L, Troiano G |
BMC oral health | 2022 |
Romosozumab and antiresorptive treatment: the importance of treatment sequence.
Cosman F, Kendler DL, Langdahl BL, Leder BZ, Lewiecki EM, Miyauchi A, Rojeski M, McDermott M, Oates MK, Milmont CE, Libanati C, Ferrari S |
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2022 |
Interest of Bone Histomorphometry in Bone Pathophysiology Investigation: Foundation, Present, and Future.
Chavassieux P, Chapurlat R |
Frontiers in Endocrinology | 2022 |
Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
HH Malluche, J Chen, F Lima, LJ Liu, MC MonierFaugere, D Pienkowski |
JBMR Plus | 2021 |
Bisphosphonates impair the onset of bone formation at remodeling sites
PR Jensen, TL Andersen, P Chavassieux, JP Roux, JM Delaisse |
Bone | 2021 |
Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis
K Aoki, S Matsunaga, S Ito, T Shibahara, T Nomura, H Matsuzaki, S Abe, A Yamaguchi |
Journal of Bone and Mineral Metabolism | 2021 |
Bone Regulators and Osteoporosis Therapy
PH Stern |
2020 | |
Bone Regulators and Osteoporosis Therapy
PH Stern |
2020 | |
Bone Regulators and Osteoporosis Therapy
PH Stern |
2020 | |
Osteoporosis Treatments Affect Bone Matrix Maturation in a Rat Model of Induced Cortical Remodeling
RD Ross, K Anderson, R Davison, BM ElMasri, CM Andreasen, TL Andersen, DR Sumner |
JBMR Plus | 2020 |
Zoledronate
IR Reid, JR Green, KW Lyles, DM Reid, U Trechsel, DJ Hosking, DM Black, SR Cummings, RG Russell, EF Eriksen |
Bone | 2020 |
Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
J Lin, S Ma, C Zhu, C Chen, W Lin, C Lin, G Huang, Z Ding |
Journal of orthopaedic surgery and research | 2020 |
The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: The T-score bone marker approach in the TRIO study
F Gossiel, MA Paggiosi, KE Naylor, EV McCloskey, J Walsh, N Peel, R Eastell |
Bone | 2020 |
Subchondral bone deterioration in femoral heads in patients with osteoarthritis secondary to hip dysplasia: A case–control study
G Li, L Chen, Q Zheng, Y Ma, C Zhang, MH Zheng |
Journal of Orthopaedic Translation | 2020 |
Comparative Analysis of Bone Mechanical Properties of Adipose-Derived Mesenchymal Stem Cells and Raloxifene in Treatment of Osteoporosis
C Piao, Z Li, J Ding, D Kong |
Journal of Hard Tissue Biology | 2020 |
Update on Menopausal Hormone Therapy for Fracture Prevention
JJ Stepan, H Hruskova, M Kverka |
Current Osteoporosis Reports | 2019 |
Reduction of Cortical Bone Turnover and Erosion Depth After 2 and 3 Years of Denosumab: Iliac Bone Histomorphometry in the FREEDOM Trial: CORTICAL ILIAC BONE HISTOMORPHOMETRY IN THE FREEDOM TRIAL
P Chavassieux, N Portero-Muzy, JP Roux, S Horlait, DW Dempster, A Wang, RB Wagman, R Chapurlat |
Journal of Bone and Mineral Research | 2019 |
Raman spectroscopy investigation shows that mineral maturity is greater in CD-1 than in C57BL/6 mice distal femurs after sexual maturity
C Fayolle, M Labrune, JP Berteau |
Connective Tissue Research | 2019 |
Pamidronate Administration During Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta
D Olvera, R Stolzenfeld, E Fisher, B Nolan, MS Caird, KM Kozloff |
Journal of Bone and Mineral Research | 2019 |
Bone‐Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment
P Chavassieux, R Chapurlat, N PorteroMuzy, JP Roux, P Garcia, JP Brown, C Libanati, RW Boyce, A Wang, A Grauer |
Journal of Bone and Mineral Research | 2019 |
Comparison of bone biomechanical properties after bone marrow mesenchymal stem cell or alendronate treatment in an osteoporotic animal model
C Piao, Z Li, J Ding, D Kong |
Biomedizinische Technik/Biomedical Engineering | 2019 |
Osteoclast-secreted SLIT3 coordinates bone resorption and formation
Beom-Jun Kim, Young-Sun Lee, Sun-Young Lee, Wook-Young Baek, Young Jin Choi, Sung Ah Moon, Seung Hun Lee, Jung-Eun Kim, Eun Ju Chang, Eun-Young Kim, Jin Yoon, Seung-Whan Kim, Sung Ho Ryu, Sun-Kyeong Lee, Joseph A. Lorenzo, Seong Hee Ahn, Hyeonmok Kim, Ki-Up Lee, Ghi Su Kim, Jung-Min Koh |
Journal of Clinical Investigation | 2018 |
Effect of Quercetin on Bone Mineral Status and Markers of Bone Turnover in Retinoic Acid-Induced Osteoporosis
N Oršolić, Ž Jeleč, J Nemrava, V Balta, G Gregorović, D Jeleč |
Polish Journal of Food and Nutrition Sciences | 2018 |
Updates in CKD-Associated Osteoporosis
P Khairallah, TL Nickolas |
Current Osteoporosis Reports | 2018 |
LRRK1 regulation of actin assembly in osteoclasts involves serine 5 phosphorylation of L-plastin: SI et al
M Si, H Goodluck, C Zeng, S Pan, EM Todd, SC Morley, X Qin, S Mohan, W Xing |
Journal of Cellular Biochemistry | 2018 |
Young’s modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years
D Pienkowski, CL Wood, HH Malluche |
Osteoporosis International | 2018 |
Osteoporosis and quality of bone
J Štěpán |
Vnitrni lekarstvi | 2018 |
Materials for Bone Disorders
SM Ott |
Materials for Bone Disorders | 2017 |
Treatment of postmenopausal osteoporosis: a literature-based algorithm for use in the public health care system
EL Caires, MC Bezerra, AF de Junqueira, SM de Fontenele, SC de Andrade, CB dAlva |
Revista Brasileira de Reumatologia (English Edition) | 2017 |
Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties
S Ma, EL Goh, A Jin, R Bhattacharya, OR Boughton, B Patel, A Karunaratne, NT Vo, R Atwood, JP Cobb, U Hansen, RL Abel |
Scientific Reports | 2017 |
Myeloproliferative Neoplasms
DL Longo, JL Spivak |
New England Journal of Medicine | 2017 |
Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats
A Takakura, JW Lee, K Hirano, Y Isogai, T Ishizuya, R Takao-Kawabata, T Iimura |
Bone Research | 2017 |
Sequential treatment with zoledronic acid followed by teriparatide or vice versa increases bone mineral density and bone strength in ovariectomized rats
T Shimizu, T Tanaka, T Kobayashi, I Kudo, M Nakatsugawa, A Takakura, R Takao-Kawabata, T Ishizuya |
Bone Reports | 2017 |
High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome: HIGH TURNOVER IN MICE WITH HAJDU-CHENEY SYNDROME
N Vollersen, I Hermans-Borgmeyer, K Cornils, B Fehse, T Rolvien, I Triviai, A Jeschke, R Oheim, M Amling, T Schinke, TA Yorgan |
Journal of Bone and Mineral Research | 2017 |
Do acid suppressive drugs (pantoprazole and ranitidine) attenuate the protective effect of alendronate in estrogen-deficient osteoporotic rats?
AS Osman, DA Labib, AI Omar |
The Egyptian Rheumatologist | 2017 |
Femoral head trabecular micro-architecture in patients with osteoporotic hip fractures: Impact of bisphosphonate treatment
BH Yoon, JG Kim, YK Lee, YC Ha, KH Koo, JH Kim |
Bone | 2017 |
Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions
EA Zimmermann, E Schaible, B Gludovatz, FN Schmidt, C Riedel, M Krause, E Vettorazzi, C Acevedo, M Hahn, K Püschel, S Tang, M Amling, RO Ritchie, B Busse |
Scientific Reports | 2016 |
Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates
J Ward, C Wood, K Rouch, D Pienkowski, HH Malluche |
Osteoporosis International | 2016 |
Zoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cells
TJ Heino, JJ Alm, HJ Halkosaari, VV Välimäki |
Acta Orthopaedica | 2016 |
Bone Biomechanics and Bone Quality: Effects of Pharmaceutical Agents Used to Treat Osteoporosis
DB Burr |
Clinical Reviews in Bone and Mineral Metabolism | 2016 |
Free Fatty Acid Receptor 4 (GPR120) Stimulates Bone Formation and Suppresses Bone Resorption in the Presence of Elevated n-3 Fatty Acid Levels
SH Ahn, SY Park, JE Baek, SY Lee, WY Baek, SY Lee, YS Lee, HJ Yoo, H Kim, SH Lee, DS Im, SK Lee, BJ Kim, JM Koh |
Endocrinology | 2016 |
Teriparatide for the rapid resolution of delayed healing of atypical fractures associated with long-term bisphosphonate use
SR Mastaglia, G Aguilar, B Oliveri |
European Journal of Rheumatology | 2016 |
Tratamento da osteoporose pós‐menopáusica: um algoritmo baseado na literatura para uso no sistema público de saúde
EL Caires, MC Bezerra, AF de Junqueira, SM de Fontenele, SC de Andrade, CB dAlva |
Revista brasileira de reumatologia | 2016 |
The Duration and Safety of Osteoporosis Treatment
S Silverman, B Abrahamsen |
2016 | |
Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation: OSTEOCLAST TGF-β RECEPTOR SIGNALING INDUCES WNT1 SECRETION
MM Weivoda, M Ruan, L Pederson, C Hachfeld, RA Davey, JD Zajac, JJ Westendorf, S Khosla, MJ Oursler |
Journal of Bone and Mineral Research | 2015 |
Bone quality and biomechanical function: A lesson from human ossicles
F Duboeuf, B Burt-Pichat, D Farlay, P Suy, E Truy, G Boivin |
Bone | 2015 |
Multi-level characterization of human femoral cortices and their underlying osteocyte network reveal trends in quality of young, aged, osteoporotic and antiresorptive-treated bone
P Milovanovic, EA Zimmermann, C Riedel, A Scheidt, L Herzog, M Krause, D Djonic, M Djuric, K Püschel, M Amling, RO Ritchie, B Busse |
Biomaterials | 2015 |
Jaw Bone Samples From Bisphosphonate-Treated Patients: A Pilot Cohort Study: Jaw Bone Samples from BP-Treated Patients
C Cardemil, P Thomsen, CL Wexell |
Clinical Implant Dentistry and Related Research | 2015 |
Three-Times-Weekly Administration of Teriparatide Improves Vertebral and Peripheral Bone Density, Microarchitecture, and Mechanical Properties Without Accelerating Bone Resorption in Ovariectomized Rats
R Takao-Kawabata, Y Isogai, A Takakura, Y Shimazu, E Sugimoto, O Nakazono, I Ikegaki, H Kuriyama, S Tanaka, H Oda, T Ishizuya |
Calcified Tissue International | 2015 |
Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease
SM Ott |
Seminars in Dialysis | 2015 |
Early Effects of Single and Low-Frequency Repeated Administration of Teriparatide, hPTH(1-34), on Bone Formation and Resorption in Ovariectomized Rats
Y Isogai, R Takao-Kawabata, A Takakura, E Sugimoto, O Nakazono, I Ikegaki, H Kuriyama, T Ishizuya |
Calcified Tissue International | 2015 |
Comparison of treatment effects of teriparatide and the bisphosphonate risedronate in an aged, osteopenic, ovariectomized rat model under various clinical conditions
A Sugie-Oya, A Takakura, R Takao-Kawabata, H Sano, Y Shimazu, Y Isogai, A Yamaguchi, T Ishizuya |
Journal of Bone and Mineral Metabolism | 2015 |
Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model
YS Chung, HC Kang, T Lee |
Yonsei Medical Journal | 2015 |
Parathyroid hormone plus alendronate in osteoporosis: a meta-analysis of randomized controlled trials
Qinggang Zhang, Jing Qian, Yuchang Zhu |
International journal of clinical and experimental medicine | 2015 |
Parathyroid Hormone Plus Alendronate in Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
C Wang, G Zhang, M Gu, J Fan, J Chen, G Zhang, B Li |
Journal of Investigative Surgery | 2015 |
From histology to micro-CT: Measuring and modeling resorption cavities and their relation to bone competence
J Vanderoost |
World journal of radiology | 2014 |
Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats
S Takeda, SY Smith, T Tamura, H Saito, F Takahashi, R Samadfam, S Haile, N Doyle, K Endo |
Calcified Tissue International | 2014 |
The Roles of Small GTPases in Osteoclast Biology
MJ Oursler |
Orthopedic & Muscular System | 2014 |
Molecular and cellular basis of bone resorption
R Gruber |
Wiener Medizinische Wochenschrift | 2014 |
Bisphosphonates and bone quality
M Pazianas, S der Geest, P Miller |
BoneKEy Reports | 2014 |
Review: Epidemiology and Pathophysiology of Atypical Femur Fractures
AC Ng, MA Png, DT Chua, JS Koh, TS Howe |
Current Osteoporosis Reports | 2014 |
Bone Histomorphometry of Transiliac Paired Bone Biopsies After 6 or 12 Months of Treatment With Oral Strontium Ranelate in 387 Osteoporotic Women: Randomized Comparison to Alendronate: EFFECTS OF SrRan VS. ALN ON BONE HISTOMORPHOMETRY
P Chavassieux, PJ Meunier, JP Roux, N Portero-Muzy, M Pierre, R Chapurlat |
Journal of Bone and Mineral Research | 2014 |
Giant osteoclasts in patients under bisphosphonates
F Mac-Way, A Trombetti, C Noel, MH Lafage-Proust |
BMC clinical pathology | 2014 |
Bisphosphonate-Related Osteonecrosis of the Jaws and Its Array of Manifestations
GD Rabelo, JN Assunção, P Chavassieux, HA Soares, FA Alves, CA Lemos |
Journal of Maxillofacial and Oral Surgery | 2014 |
Does mechanical stimulation really protect the architecture of trabecular bone? A simulation study
MM Maurer, R Weinkamer, R Müller, D Ruffoni |
Biomechanics and Modeling in Mechanobiology | 2014 |
Bone safety with risedronate: histomorphometric studies at different dose levels and exposure
RR Recker, LG Ste-Marie, P Chavassieux, MR McClung, MW Lundy |
Osteoporosis International | 2014 |
Bisphosphonate-osteoclasts: Changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients
B Jobke, P Milovanovic, M Amling, B Busse |
Bone | 2014 |
Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment
YL Ma, QQ Zeng, AY Chiang, D Burr, J Li, H Dobnig, A Fahrleitner-Pammer, D Michalská, F Marin, I Pavo, JJ Stepan |
Bone | 2014 |
A large amount of microdamages in the cortical bone around fracture site in a patient of atypical femoral fracture after long-term bisphosphonate therapy
K Iwata, T Mashiba, T Hitora, Y Yamagami, T Yamamoto |
Bone | 2014 |
Evaluating optimal combination of clodronate and bioactive glass for dental application
K Rosenqvist, S Airaksinen, M Vehkamäki, AM Juppo |
International Journal of Pharmaceutics | 2014 |
Bisphosphonates and Connexin 43: A Critical Review of Evidence
P Sadr-Eshkevari, S Ashnagar, A Rashad, M Dietz, J Jackowski, A Abdulazim, N Prochnow |
Cell communication & adhesion | 2014 |
Inhibition of Cathepsin K Increases Modeling-Based Bone Formation, and Improves Cortical Dimension and Strength in Adult Ovariectomized Monkeys: ODANACATIB STIMULATES CORTICAL BONE FORMATION IN OVARIECTOMIZED MONKEYS
BL Pennypacker, CM Chen, H Zheng, MS Shih, M Belfast, R Samadfam, LT Duong |
Journal of Bone and Mineral Research | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Mathematical modeling of postmenopausal osteoporosis and its treatment by the anti-catabolic drug denosumab: MATHEMATICAL MODELING OF OSTEOPOROSIS TREATMENT BY DENOSUMAB
S Scheiner, P Pivonka, DW Smith, CR Dunstan, C Hellmich |
International Journal for Numerical Methods in Biomedical Engineering | 2013 |
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
J Jeyabalan, B Viollet, P Smitham, SA Ellis, G Zaman, C Bardin, A Goodship, JP Roux, M Pierre, C Chenu |
Osteoporosis International | 2013 |
Bisphosphonate Treatment for Children With Disabling Conditions
AM Boyce, LL Tosi, SM Paul |
PM&R | 2013 |
An In Vitro Assessment of Fibroblast and Osteoblast Response to Alendronate-Modified Titanium and the Potential for Decreasing Fibrous Encapsulation
X Hu, KG Neoh, Z Shi, ET Kang, W Wang |
Tissue Engineering Part A | 2013 |
Micro-morphological properties of osteons reveal changes in cortical bone stability during aging, osteoporosis, and bisphosphonate treatment in women
A Bernhard, P Milovanovic, EA Zimmermann, M Hahn, D Djonic, M Krause, S Breer, K Püschel, M Djuric, M Amling, B Busse |
Osteoporosis International | 2013 |
Anti-resorptive Agents Reduce the Size of Resorption Cavities: A Three-Dimensional Dynamic Bone Histomorphometry Study
JB Matheny, CR Slyfield, EV Tkachenko, I Lin, KM Ehlert, RE Tomlinson, DL Wilson, CJ Hernandez |
Bone | 2013 |
Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: A comparison with alfacalcidol and alendronate
M Sugimoto, N Futaki, M Harada, S Kaku |
Bone | 2013 |
Alendronate protects against articular cartilage erosion by inhibiting subchondral bone loss in ovariectomized rats
S Zhu, K Chen, Y Lan, N Zhang, R Jiang, J Hu |
Bone | 2013 |
The effect of resorption cavities on bone stiffness is site dependent
J Vanderoost, GH van Lenthe |
Computer Methods in Biomechanics and Biomedical Engineering | 2013 |
Proposed pathogenesis for atypical femoral fractures: Lessons from material research
B Ettinger, DB Burr, RO Ritchie |
Bone | 2013 |
Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort
BM Misof, P Roschger, D Gabriel, EP Paschalis, EF Eriksen, RR Recker, JA Gasser, K Klaushofer |
Journal of Bone and Mineral Research | 2013 |
Retrospective analysis of 27 cases of bisphosphonate-related osteonecrosis of the jaw treated surgically or nonsurgically
SY Lu, CC Liang, LH Lin |
Journal of Dental Sciences | 2013 |
Osteoporosis: Diagnosis and Management
S Silverman, S Venuturupalli |
Osteoporosis: Diagnosis and Management | 2013 |
The Bone Resorption Inhibitors Odanacatib and Alendronate Affect Post-Osteoclastic Events Differently in Ovariectomized Rabbits
PR Jensen, TL Andersen, BL Pennypacker, LT Duong, JM Delaissé |
Calcified Tissue International | 2013 |
Effect of alendronate on bone remodeling around implant in the rat
R Park, JH Kim, H Choi, YB Park, HS Jung, HS Moon |
The journal of advanced prosthodontics | 2013 |
Therapy for patients with CKD and low bone mineral density
SM Ott |
Nature Reviews Nephrology | 2013 |
Eliminating the need for fasting with oral administration of bisphosphonates
M Pazianas, B Abrahamsen, S Ferrari, RG Russell |
Therapeutics and Clinical Risk Management | 2013 |
Epidemiology, radiology and histology of atypical femoral fractures: Development of understanding
J Schilcher |
Acta Orthopaedica | 2013 |
Bisphosphonates and adipogenesis: Evidence for alendronate inhibition of adipocyte differentiation in 3T3-L1 preadipocytes through a vitamin D receptor mediated effect
C Mammi, M Calanchini, A Antelmi, A Feraco, L Gnessi, S Falcone, F Quintarelli, GM Rosano, A Fabbri, M Caprio |
Natural Science | 2013 |
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice
SD Kim, HN Kim, JH Lee, WJ Jin, SJ Hwang, HH Kim, H Ha, ZH Lee |
Biochemical Pharmacology | 2013 |
Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects
K Vandyke, S Fitter, J Drew, S Fukumoto, CG Schultz, NA Sims, DT Yeung, TP Hughes, AC Zannettino |
The Journal of clinical endocrinology and metabolism | 2013 |
Spontaneous Non-Traumatic Stress Fractures in Bilateral Femoral Shafts in a Patient Treated with Bisphosphonates
DY Shin, CR Ku, KM Kim, HS Choi, Y Rhee, EJ Lee, SK Lim |
The Korean Journal of Internal Medicine | 2012 |
Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization
Y Bala, B Depalle, D Farlay, T Douillard, S Meille, H Follet, R Chapurlat, J Chevalier, G Boivin |
Journal of Bone and Mineral Research | 2012 |
Histomorphometric interpretation of bone biopsies for the evaluation of osteoporosis treatment
JE Compston |
BoneKEy Reports | 2012 |
Mice lacking AMP-activated protein kinase α1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment
J Jeyabalan, M Shah, B Viollet, JP Roux, P Chavassieux, M Korbonits, C Chenu |
The Journal of endocrinology | 2012 |
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
F Jakob, H Oertel, B Langdahl, O Ljunggren, A Barrett, D Karras, JB Walsh, A Fahrleitner-Pammer, G Rajzbaum, C Barker, WF Lems, F Marin |
European Journal of Endocrinology | 2012 |
Effects of Low Dose Doxycycline and Bisphosphonate Clodronate on Gingival Levels of Matrix Metalloproteinase -9, Interleukin -1B and Alveolar Bone Loss in Diabetic Rats. A Histomorphometric and Immunohistochemical Study
SP Özdemir, B Kurtiş, G Tüter, Ş Bozkurt, SE Gültekin, B Sengüven, K Watanabe, S Aydın |
Journal of Periodontology | 2012 |
Afamin secreted from nonresorbing osteoclasts acts as a chemokine for preosteoblasts via the Akt-signaling pathway
BJ Kim, YS Lee, SY Lee, SY Park, H Dieplinger, SH Ryu, K Yea, S Choi, SH Lee, JM Koh, GS Kim |
Bone | 2012 |
Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women
LA Fitzpatrick, CE Dabrowski, G Cicconetti, DN Gordon, T Fuerst, K Engelke, HK Genant |
Journal of Bone and Mineral Research | 2012 |
Importance of reversible remodeling suppression with denosumab
RR Recker |
IBMS BoneKEy | 2012 |
Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces
B Hofstetter, S Gamsjaeger, RJ Phipps, RR Recker, FH Ebetino, K Klaushofer, EP Paschalis |
Journal of Bone and Mineral Research | 2012 |
Computed tomography, histological and ultrasonic measurements of adolescent scoliotic rib hump geometrical and material properties
JP Berteau, M Pithioux, H Follet, C Guivier-Curien, P Lasaygues, P Chabrand |
Journal of Biomechanics | 2012 |
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
MR McClung, A Balske, DE Burgio, D Wenderoth, RR Recker |
Osteoporosis International | 2012 |
Bone mineralization: from tissue to crystal in normal and pathological contexts
Y Bala, D Farlay, G Boivin |
Osteoporosis International | 2012 |
Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals
G Zhang, R Huang, Z Li, X Yang, X Chen, W Xia, X Sun, G Yang, C Gao, Z Gou |
Journal of Inorganic Biochemistry | 2012 |
Oral Ibandronate in Postmenopausal Osteoporotic Women Alters Micromechanical Properties Independently of Changes in Mineralization
Y Bala, J Kohles, RR Recker, G Boivin |
Calcified Tissue International | 2012 |
Histopathological features of bisphosphonate-associated osteonecrosis: findings in patients treated with partial mandibulectomies
YA Cho, HJ Yoon, JI Lee, SP Hong, SD Hong |
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology | 2012 |
Antiresorptive drugs (bisphosphonates), atypical fractures and rebound effect: new evidence of similitude
MZ Teixeira |
Homeopathy | 2012 |
Bisphosphonates Use in Children
JF Sebestyen, T Srivastava, US Alon |
Clinical Pediatrics | 2012 |
Osteoclast Activity and Subtypes as a Function of Physiology and Pathology—Implications for Future Treatments of Osteoporosis
K Henriksen, J Bollerslev, V Everts, MA Karsdal |
Endocrine reviews | 2011 |
A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
LI Plotkin, N Bivi, T Bellido |
Bone | 2011 |
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
T Bellido, LI Plotkin |
Bone | 2011 |
Denosumab and bisphosphonates: Different mechanisms of action and effects
R Baron, S Ferrari, RG Russell |
Bone | 2011 |
Effect of Bisphosphonates on the Progression of Degenerative Aortic Stenosis
AL Innasimuthu, WE Katz |
Echocardiography | 2011 |
Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know
MR Allen, DB Burr |
Bone | 2011 |
A Fracture Does Not Adversely Affect Bone Mineral Density Responses after Teriparatide Treatment
A Unnanuntana, QV Ton, JP Kleimeyer, JT Nguyen, JM Lane |
Clinical Orthopaedics and Related Research® | 2011 |
Atypical diaphyseal femoral fractures—new aspects
F Feldman |
Skeletal Radiology | 2011 |
Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence – a multi-centre study
S Otto, MH Abu-Id, S Fedele, PH Warnke, ST Becker, A Kolk, T Mücke, G Mast, R Köhnke, E Volkmer, F Haasters, O Lieger, T Iizuka, S Porter, G Campisi, G Colella, O Ploder, A Neff, J Wiltfang, M Ehrenfeld, T Kreusch, KD Wolff, SR Stürzenbaum, M Schieker, C Pautke |
Journal of Cranio-Maxillofacial Surgery | 2011 |
Safety of bisphosphonates
M Pazianas, B Abrahamsen |
Bone | 2011 |
Physiology of the aging bone and mechanisms of action of bisphosphonates
LJ Dominguez, G Bella, M Belvedere, M Barbagallo |
Biogerontology | 2011 |
Bisphosphonates for postmenopausal osteoporosis
R Eastell, JS Walsh, NB Watts, E Siris |
Bone | 2011 |
Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient
S Battaglia, S Dumoucel, J Chesneau, MF Heymann, G Picarda, F Gouin, N Corradini, D Heymann, F Redini |
Journal of Bone and Mineral Research | 2011 |
Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner – A quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2
FP Koch, C Merkel, B Al-Nawas, R Smeets, T Ziebart, C Walter, W Wagner |
Journal of Cranio-Maxillofacial Surgery | 2011 |
The potential value of monitoring bone turnover markers among women on alendronate
KJ Bell, A Hayen, L Irwig, MC Hochberg, KE Ensrud, SR Cummings, DC Bauer |
Journal of Bone and Mineral Research | 2011 |
Bisphosphonates and Atypical Fractures of Femur
T Yli-Kyyny |
Journal of osteoporosis | 2011 |
Effects of Short-Term Zoledronic Acid Treatment on Bone Remodeling and Healing at Surgical Sites in the Maxilla and Mandible of Aged Dogs
SS Huja, A Mason, CE Fenell, X Mo, S Hueni, AM D'Atri, SA Fernandez |
Journal of Oral and Maxillofacial Surgery | 2011 |
Medical Treatment of Osteoporotic Vertebral Fractures
BL Langdahl, T Harsløf |
Therapeutic Advances in Musculoskeletal Diseases | 2011 |
Trabecular Reorganization in Consecutive Iliac Crest Biopsies when Switching from Bisphosphonate to Strontium Ranelate Treatment
B Jobke, AJ Burghardt, B Muche, M Hahn, J Semler, M Amling, S Majumdar, B Busse, WC Chin |
PloS one | 2011 |
Obesity and osteoporosis
VN Shishkova, VN Shishkova |
Osteoporosis and osteopathy | 2011 |
Skeletal Aging and Osteoporosis
MJ Silva |
2011 | |
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis: Results of a 2-year study
R Rizzoli, RD Chapurlat, JM Laroche, MA Krieg, T Thomas, I Frieling, S Boutroy, A Laib, O Bock, D Felsenberg |
Osteoporosis International | 2011 |
Burger's Medicinal Chemistry and Drug Discovery
S Bruno, L Ronda, S Faggiano, S Bettati, A Mozzarelli |
Burger's Medicinal Chemistry and Drug Discovery | 2010 |
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
JJ Stepan, DB Burr, J Li, YL Ma, H Petto, A Sipos, H Dobnig, A Fahrleitner-Pammer, D Michalská, I Pavo |
Osteoporosis International | 2010 |
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis
R Rizzoli, M Laroche, MA Krieg, I Frieling, T Thomas, P Delmas, D Felsenberg |
Rheumatology International | 2010 |
Effects of alendronate on bone healing after tooth extraction in rats
JI Aguirre, MK Altman, SM Vanegas, SE Franz, AC Bassit, TJ Wronski |
Oral Diseases | 2010 |
Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading
A Feher, A Koivunemi, M Koivunemi, RK Fuchs, DB Burr, RJ Phipps, S Reinwald, MR Allen |
Bone | 2010 |
The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro
FP Koch, SS Yekta, C Merkel, T Ziebart, R Smeets |
Head & face medicine | 2010 |
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
M Pazianas, C Cooper, FH Ebetino, RG Russell |
Therapeutics and Clinical Risk Management | 2010 |
Radiology of Osteoporosis
G Anil, G Guglielmi, WC Peh |
Radiologic Clinics of North America | 2010 |
Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture
S Ferrari |
Osteoporosis International | 2010 |
Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate
KH Yang, SY Park, SW Park, SH Lee, SB Han, WK Jung, SJ Kim |
Journal of Bone and Mineral Metabolism | 2010 |
Use of bisphosphonates in the management of postmenopausal osteoporosis
SE Papapoulos |
Annals of the New York Academy of Sciences | 2010 |
Atypical fractures of the femur and bisphosphonate therapy
A Giusti, NA Hamdy, SE Papapoulos |
Bone | 2010 |
Bilateral Femoral Subtrochanteric Insufficiency Fractures after Long-term Bisphosphonate Therapy
JG Park, KS Song, HJ Jung, JS Lee, TJ Lee, KS Kim |
Journal of the Korean Orthopaedic Association | 2010 |
Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
IR Reid, PD Miller, JP Brown, DL Kendler, A Fahrleitner-Pammer, I Valter, K Maasalu, MA Bolognese, G Woodson, H Bone, B Ding, RB Wagman, JS Martin, MS Ominsky, DW Dempster |
Journal of Bone and Mineral Research | 2010 |
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
RR Recker, LG Ste-Marie, B Langdahl, E Czerwinski, B Bonvoisin, D Masanauskaite, L Rowell, D Felsenberg |
Bone | 2010 |
Association between collagen cross-links and trabecular microarchitecture properties of human vertebral bone
S Viguet-Carrin, H Follet, E Gineyts, JP Roux, F Munoz, R Chapurlat, PD Delmas, ML Bouxsein |
Bone | 2010 |
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
E Shane, D Burr, PR Ebeling, B Abrahamsen, RA Adler, TD Brown, AM Cheung, F Cosman, JR Curtis, R Dell, D Dempster, TA Einhorn, HK Genant, P Geusens, K Klaushofer, K Koval, JM Lane, F McKiernan, R McKinney, A Ng, J Nieves, R O'Keefe, S Papapoulos, HT Sen, MC van der Meulen, RS Weinstein, M Whyte |
Journal of Bone and Mineral Research | 2010 |
Effect of Risedronate on Osteocyte Viability and Bone Turnover in Paired Iliac Bone Biopsies from Early Postmenopausal Women
S Qiu, RJ Phipps, FH Ebetino, S Palnitkar, DS Rao |
Calcified Tissue International | 2010 |
Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review
SJ Gallacher, T Dixon |
Calcified Tissue International | 2010 |
Bone histomorphometry: a concise review for endocrinologists and clinicians
CA Kulak, DW Dempster |
Arquivos brasileiros de endocrinologia e metabologia | 2010 |
Atlas of Postmenopausal Osteoporosis
R Rizzoli |
2010 | |
Giant osteoclast formation and long-term oral bisphosphonate therapy
RS Weinstein, PK Roberson, SC Manolagas |
The New England journal of medicine | 2009 |
Bisphosphonates and BMU birth rate: response to comments by Ott
E Seeman |
Osteoporosis International | 2009 |
Safety and Efficacy of Intravenous Zoledronic Acid in Paediatric Osteoporosis
JJ Brown, MR Zacharin |
Journal of Pediatric Endocrinology and Metabolism | 2009 |
Progress in osteoporosis and fracture prevention: focus on postmenopausal women
KG Saag, P Geusens |
Arthritis Research & Therapy | 2009 |
Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone
MR Allen, AM Erickson, X Wang, DB Burr, RB Martin, SJ Hazelwood |
Calcified Tissue International | 2009 |
Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage
X Wang, AM Erickson, MR Allen, DB Burr, RB Martin, SJ Hazelwood |
Journal of Biomechanics | 2009 |
Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?
L Kolios, AK Hoerster, S Sehmisch, MC Malcherek, T Rack, M Tezval, D Seidlova-Wuttke, W Wuttke, KM Stuermer, EK Stuermer |
Calcified Tissue International | 2009 |
Eel calcitonin (elcatonin) suppressed callus remodeling but did not interfere with fracture healing in the femoral fracture model of cynomolgus monkeys
T Manabe, S Mori, T Mashiba, Y Cao, Y Kaji, K Iwata, S Komatsubara, T Yamamoto, A Seki, H Norimatsu |
Journal of Bone and Mineral Metabolism | 2009 |
Potential effects of bisphosphonates on bone ultrastructure
C Roux |
Osteoporosis International | 2009 |
Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: An analysis of 31 cases with confocal laser scanning microscopy
G Favia, GP Pilolli, E Maiorano |
Bone | 2009 |
Are bisphosphonates effective and safe in patients with low serum vitamin D levels?
WF Lems, P Geusens |
International Journal of Clinical Rheumatology | 2009 |
Inhibition of osteoblast function in vitro by aminobisphosphonates
IR Orriss, ML Key, KW Colston, TR Arnett |
Journal of Cellular Biochemistry | 2009 |
Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX)
P Roschger, A Lombardi, BM Misof, G Maier, N Fratzl-Zelman, P Fratzl, K Klaushofer |
Journal of Bone and Mineral Research | 2009 |
The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits
JG Hofstaetter, J Wang, J Yan, MJ Glimcher |
Osteoarthritis and Cartilage | 2009 |
Zoledronic acid decreases bone formation without causing osteocyte death in mice
SS Huja, SA Fernandez, C Phillips, Y Li |
Archives of Oral Biology | 2009 |
Osteonecrosis of the Jaw and the Role of Bisphosphonates: A Critical Review
SL Silverman, R Landesberg |
The American Journal of Medicine | 2009 |
The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women
A Grey, MJ Bolland, D Wattie, A Horne, G Gamble, IR Reid |
The Journal of clinical endocrinology and metabolism | 2009 |
Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra
T Diab, MR Allen, DB Burr |
Osteoporosis International | 2008 |
In Vivo Magnetic Resonance Detects Rapid Remodeling Changes in the Topology of the Trabecular Bone Network After Menopause and the Protective Effect of Estradiol
FW Wehrli, GA Ladinsky, C Jones, M Benito, J Magland, B Vasilic, AM Popescu, B Zemel, AJ Cucchiara, AC Wright, HK Song, PK Saha, H Peachey, PJ Snyder |
Journal of Bone and Mineral Research | 2008 |
Bisphosphonat-assoziierte Osteonekrosen des Kieferknochens
MT Krauth, A Fügl, R Gruber |
Wiener klinische Wochenschrift | 2008 |
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
RG Russell, NB Watts, FH Ebetino, MJ Rogers |
Osteoporosis International | 2008 |
Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
JJ Brown, L Ramalingam, MR Zacharin |
Clinical Endocrinology | 2008 |
Combination Therapy Using Exercise and Pharmaceutical Agents to Optimize Bone Health
RK Fuchs, SJ Warden |
Clinical Reviews in Bone and Mineral Metabolism | 2008 |
Bisphosphonates: how do they work?
SE Papapoulos |
Best Practice & Research Clinical Endocrinology & Metabolism | 2008 |
Surface-specific Bone Formation Effects of Osteoporosis Pharmacological Treatments
MR Allen |
Clinical Reviews in Bone and Mineral Metabolism | 2008 |
Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench
MR Allen |
Cells, tissues, organs | 2008 |
Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
AL Boskey, L Spevak, RS Weinstein |
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2008 |
Osteoporosis: how long should we treat?
A Sebba |
Current Opinion in Endocrinology, Diabetes and Obesity | 2008 |
Beneficial Effects of Combined Administration of Alendronate and Alfacalcidol on Cancellous Bone Mass of the Tibia in Orchidectomized Rats: A Bone Histomorphometry Study
J IWAMOTO, T TAKEDA, H MATSUMOTO, Y SATO, JK YEH |
Journal of Nutritional Science and Vitaminology | 2008 |
Effect of Temporal Changes in Bone Turnover on the Bone Mineralization Density Distribution: A Computer Simulation Study
D Ruffoni, P Fratzl, P Roschger, R Phipps, K Klaushofer, R Weinkamer |
Journal of Bone and Mineral Research | 2008 |
Uptake of calcium phosphate nanoshells by osteoblasts and their effect on growth and differentiation
SM Schmidt, KA Moran, AM Kent, JL Slosar, MJ Webber, MJ McCready, C Deering, JM Veranth, A Ostafin |
Journal of Biomedical Materials Research Part A | 2008 |
Zoledronic acid – does it have anabolic as well as anti-resorptive effects?
JE Compston |
IBMS BoneKEy | 2008 |
Principles of Bone Biology
CJ Rosen, T Niu |
Principles of Bone Biology | 2008 |
Effect of inappropriate and continuous therapy with alendronate for ten years on skeletal integrity — Observations in two elderly patients
JR Tucci |
Journal of Endocrinological Investigation | 2008 |
Teriparatide in the treatment of osteoporosis
J Stroup, MP Kane, AM Abu-Baker |
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2008 |
Severely Suppressed Bone Turnover and Atypical Skeletal Fragility
M Visekruna, D Wilson, FE McKiernan |
The Journal of clinical endocrinology and metabolism | 2008 |
Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate
ME Arlot, Y Jiang, HK Genant, J Zhao, B Burt-Pichat, JP Roux, PD Delmas, PJ Meunier |
Journal of Bone and Mineral Research | 2007 |
1α,25-Dihydroxy-2β(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora
Y Cao, S Mori, T Mashiba, Y Kaji, T Manabe, K Iwata, K Miyamoto, S Komatsubara, T Yamamoto |
Bone | 2007 |
Recent Developments in Bisphosphonate Therapy
SL Silverman, M Maricic |
Seminars in Arthritis and Rheumatism | 2007 |
Combination therapy for treatment of osteoporosis: A review
JA Pinkerton, AC Dalkin |
American Journal of Obstetrics and Gynecology | 2007 |
Anabolic effects of bisphosphonates on peri-implant bone stock
F Knoch, C Eckhardt, CI Alabre, E Schneider, HE Rubash, AS Shanbhag |
Biomaterials | 2007 |
Alendronate Has an Anabolic Effect on Bone Through the Differentiation of Mesenchymal Stem Cells
G Duque, D Rivas |
Journal of Bone and Mineral Research | 2007 |
Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate
CJ Wang, FS Wang, KD Yang, CC Huang, MS Lee, YS Chan, JW Wang, JY Ko |
Archives of Orthopaedic and Trauma Surgery | 2007 |
Skeletal bone diseases impact the periodontium: a review of bisphosphonate therapy
L Palomo, J Liu, NF Bissada |
Expert Opinion on Pharmacotherapy | 2007 |
Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis
JJ Stepan, DB Burr, I Pavo, A Sipos, D Michalska, J Li, A Fahrleitner-Pammer, H Petto, M Westmore, D Michalsky, M Sato, H Dobnig |
Bone | 2007 |
Composite Nanocrystals Provide New Insight on Alendronate Interaction with Hydroxyapatite Structure
E Boanini, M Gazzano, K Rubini, A Bigi |
Advanced Materials | 2007 |
Effect of combined humanPTH(1–34) and calcitonin treatment in ovariectomized rats
Y Washimi, M Ito, Y Morishima, K Taguma, Y Ojima, T Uzawa, M Hori |
Bone | 2007 |
Bisphosphonate antifracture efficacy
S Adami |
Bone | 2007 |
Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure
RR Recker, PD Delmas, J Halse, IR Reid, S Boonen, PA García-Hernandez, J Supronik, EM Lewiecki, L Ochoa, P Miller, H Hu, P Mesenbrink, F Hartl, J Gasser, EF Eriksen |
Journal of Bone and Mineral Research | 2007 |
Skeletal actions of intermittent parathyroid hormone: Effects on bone remodelling and structure
JE Compston |
Bone | 2007 |
Two-Year Changes in Bone Mineral Density and T Scores in Patients Treated at a Pharmacist-Run Teriparatide Clinic
JS Stroup, SM Rivers, AM Abu-Baker, MP Kane |
Pharmacotherapy | 2007 |
Bisphosphonate treatment and fracture repair
MM McDonald, A Schindeler, DG Little |
BoneKEy-Osteovision | 2007 |
REZUL'TATY ROSSIYSKOGO MNOGOTsENTROVOGO ISSLEDOVANIYa EFFEKTIVNOSTI I PERENOSIMOSTIBIVALOSA (STRONTsIYa RANELATA) U ZhENShchINS POSTMENOPAUZAL'NYM OSTEOPOROZOM
LY ROZhINSKAYa, SD Arapova, LK Dzeranova, NN Molitvoslovova, EI Marova, AA ShIShKINA, NI Sazonova, TO ChERNOVA, AV Il'in, LI BENEVOLENSKAYa, OA NIKITINSKAYa, TA Korotkova, NV TOROPTsOVA, AV Smirnov, NV Demin, SS Rodionova, YV BUKLEMEShEV, AA ShUMSKIY |
Osteoporosis and osteopathy | 2007 |
Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children
KM Waterhouse, A Auron, T Srivastava, C Haney, US Alon |
Pediatric Nephrology | 2007 |
Teriparatide Increases Bone Formation in Modeling and Remodeling Osteons and Enhances IGF-II Immunoreactivity in Postmenopausal Women With Osteoporosis
YL Ma, Q Zeng, DW Donley, LG Ste-Marie, JC Gallagher, GP Dalsky, R Marcus, EF Eriksen |
Journal of Bone and Mineral Research | 2006 |
Preservation of thoracic spine microarchitecture by alendronate: Comparison of histology and microCT
LD Hordon, M Itoda, PA Shore, RC Shore, M Heald, M Brown, JA Kanis, GA Rodan, JE Aaron |
Bone | 2006 |
Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis
J Iwamoto, T Takeda, Y Sato |
Current Medical Research and Opinion | 2006 |
Antiremodeling Agents Influence Osteoblast Activity Differently in Modeling and Remodeling Sites of Canine Rib
MR Allen, H Follet, M Khurana, M Sato, DB Burr |
Calcified Tissue International | 2006 |
Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs
LI Plotkin, SC Manolagas, T Bellido |
Bone | 2006 |
Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients
H Dobnig, LC Hofbauer, V Viereck, B Obermayer-Pietsch, A Fahrleitner-Pammer |
Osteoporosis International | 2006 |
HRT: Have we changed?
O Conlon, K McKinney |
Irish Journal of Medical Science | 2006 |
Anabolic therapy for osteoporosis: Parathyroid hormone
F Cosman |
Current Rheumatology Reports | 2006 |
Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia
K Iwata, J Li, H Follet, RJ Phipps, DB Burr |
Bone | 2006 |
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
MR Allen, K Iwata, R Phipps, DB Burr |
Bone | 2006 |
Drug Insight: bisphosphonates for postmenopausal osteoporosis
RD Chapurlat, PD Delmas |
Nature Clinical Practice Endocrinology & Metabolism | 2006 |
Drug Insight: existing and emerging therapies for osteoporosis
JE Mulder, NS Kolatkar, MS LeBoff |
Nature Clinical Practice Endocrinology & Metabolism | 2006 |
Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children
KM Waterhouse, A Auron, T Srivastava, C Haney, US Alon |
Pediatric Nephrology | 2006 |
Update of current therapeutic options for the treatment of postmenopausal osteoporosis
S Epstein |
Clinical Therapeutics | 2006 |
Predictions on Preserving Bone Mass in Knee Arthroplasty With Bisphosphonates
JS Nyman, JJ Rodrigo, SJ Hazelwood, OC Yeh, RB Martin |
The Journal of Arthroplasty | 2006 |
Osteoporosis: How Should It Be Treated?
CV Odvina |
Journal of Investigative Medicine | 2006 |
Use of Bisphosphonates to Improve the Durability of Total Joint Replacements:
AS Shanbhag |
The Journal of the American Academy of Orthopaedic Surgeons | 2006 |
Metabolic Bone Disease in Patients Receiving Home Parenteral Nutrition: A Canadian Study and Review
M Raman, E Aghdassi, M Baun, M Yeung, L Fairholm, O Saqui, JP Allard |
JPEN. Journal of parenteral and enteral nutrition | 2006 |
Selective estrogen receptor modulators (SERMS)
A Diez-Perez |
Arquivos brasileiros de endocrinologia e metabologia | 2006 |
Selective Estrogen Receptor Modulators
AC Sanchez, JC i Alsina, JL Dueñas-Díez |
2006 | |
Bisphosphonates: From Bench to Bedside
RG Russell |
Annals of the New York Academy of Sciences | 2006 |
Long-Term Safety of Bisphosphonate Therapy for Osteoporosis: A Review of the Evidence
UA Liberman |
Drugs & Aging | 2006 |
Parathyroid hormone for the treatment of osteoporosis: a systematic review.
Cranney A, Papaioannou A, Zytaruk N, Hanley D, Adachi J, Goltzman D, Murray T, Hodsman A |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2006 |
Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene
LM Helvering, R Liu, NH Kulkarni, T Wei, P Chen, S Huang, F Lawrence, DL Halladay, RR Miles, EM Ambrose, M Sato, YL Ma, CA Frolik, ER Dow, HU Bryant, JE Onyia |
Molecular pharmacology | 2005 |
Histomorphometric analysis of glucocorticoid-induced osteoporosis
LD Carbonare, F Bertoldo, MT Valenti, S Zenari, M Zanatta, S Sella, S Giannini, VL Cascio |
Micron | 2005 |
Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats
W Yao, T Hadi, Y Jiang, J Lotz, TJ Wronski, NE Lane |
Osteoporosis International | 2005 |
High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse
CY Li, RJ Majeska, DM Laudier, R Mann, MB Schaffler |
Bone | 2005 |
Microdamage accumulation in the monkey vertebra does not occur when bone turnover is suppressed by 50% or less with estrogen or raloxifene
J Li, M Sato, C Jerome, CH Turner, Z Fan, DB Burr |
Journal of Bone and Mineral Metabolism | 2005 |
The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats
H Kajiwara, T Yamaza, M Yoshinari, T Goto, S Iyama, I Atsuta, MA Kido, T Tanaka |
Biomaterials | 2005 |
Bisphosphonate Modulates Cementoblast Behavior In Vitro
YH Chun, BL Foster, PA Lukasavage, JE Berry, M Zhao, HC Tenenbaum, MJ Somerman |
Journal of Periodontology | 2005 |
Clinical Pharmacology of Potent New Bisphosphonates for Postmenopausal Osteoporosis
RD Chapurlat |
Treatments in Endocrinology | 2005 |
Bone Remodeling at the Iliac Crest Can Predict the Changes in Remodeling Dynamics, Microdamage Accumulation, and Mechanical Properties in the Lumbar Vertebrae of Dogs
T Mashiba, S Hui, CH Turner, S Mori, CC Johnston, DB Burr |
Calcified Tissue International | 2005 |
Anabolic therapy for osteoporosis: Parathyroid hormone
F Cosman |
Current Osteoporosis Reports | 2005 |
Effects of Salmon Calcitonin on Trabecular Microarchitecture as Determined by Magnetic Resonance Imaging: Results From the QUEST Study
CH Chesnut, S Majumdar, DC Newitt, A Shields, JV Pelt, E Laschansky, M Azria, A Kriegman, M Olson, EF Eriksen, L Mindeholm |
Journal of Bone and Mineral Research | 2005 |
Regulation of apoptosis in osteoclasts and osteoblastic cells
L Xing, BF Boyce |
Biochemical and Biophysical Research Communications | 2005 |
Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells
F Knoch, C Jaquiery, M Kowalsky, S Schaeren, C Alabre, I Martin, HE Rubash, AS Shanbhag |
Biomaterials | 2005 |
Emerging concepts in osteoporosis and bone strength
CD Rubin |
Current Medical Research and Opinion | 2005 |
Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters
M Arlot, PJ Meunier, G Boivin, L Haddock, J Tamayo, R Correa-Rotter, S Jasqui, DW Donley, GP Dalsky, JS Martin, EF Eriksen |
Journal of Bone and Mineral Research | 2005 |
Bone Disease of Organ Transplantation
MR Rubin, JP Billezkian |
Bone Disease of Organ Transplantation | 2005 |
A rational approach to evidence gaps in the management of osteoporosis
CJ Rosen, SA Brown |
The American Journal of Medicine | 2005 |
Bone microarchitecture evaluated by histomorphometry
LD Carbonare, MT Valenti, F Bertoldo, M Zanatta, S Zenari, G Realdi, VL Cascio, S Giannini |
Micron (Oxford, England : 1993) | 2005 |
The influence of alendronate on bone formation after autogenous free bone grafting in rats
H Altundal, B Gursoy |
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology | 2005 |
Pharmacokinetics/Pharmacodynamics of Bisphosphonates: Use for Optimisation of Intermittent Therapy for Osteoporosis
SC Cremers, GC Pillai, SE Papapoulos |
Clinical Pharmacokinetics | 2005 |
Pharmacological Management of Severe Postmenopausal Osteoporosis:
A Gaudio, N Morabito |
Drugs & Aging | 2005 |
Bone Resorption
F Bronner, MC Farach-Carson, J Rubin |
2005 | |
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
AB Hodsman, DC Bauer, DW Dempster, L Dian, DA Hanley, ST Harris, DL Kendler, MR McClung, PD Miller, WP Olszynski, E Orwoll, CK Yuen |
Endocrine reviews | 2005 |
Long-Term Safety of Bisphosphonates
SM Ott |
The Journal of clinical endocrinology and metabolism | 2005 |
The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model
T Hayami, M Pickarski, GA Wesolowski, J Mclane, A Bone, J Destefano, GA Rodan, LT Duong |
Arthritis & Rheumatism | 2004 |
Cochrane Database of Systematic Reviews
L Hooper, C Bartlett, GD Smith, S Ebrahim, L Hooper |
Cochrane Database of Systematic Reviews | 2004 |
Drugs Used to Treat Osteoporosis: The Critical Need for a Uniform Nomenclature Based on Their Action on Bone Remodeling
BL Riggs, AM Parfitt |
Journal of Bone and Mineral Research | 2004 |
A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage
JS Nyman, OC Yeh, SJ Hazelwood, RB Martin |
Bone | 2004 |
Bone safety of long-term bisphosphonate treatment
G Rodan, A Reszka, E Golub, R Rizzoli |
Current Medical Research and Opinion | 2004 |
Osteoblast proliferation and maturation by bisphosphonates
GI Im, SA Qureshi, J Kenney, HE Rubash, AS Shanbhag |
Biomaterials | 2004 |
Long-term effects of neridronate on human osteoblastic cell cultures
B Frediani, A Spreafico, C Capperucci, F Chellini, D Gambera, P Ferrata, F Baldi, P Falsetti, A Santucci, L Bocchi, R Marcolongo |
Bone | 2004 |
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro
B Pan, LB To, AN Farrugia, DM Findlay, J Green, S Gronthos, A Evdokiou, K Lynch, GJ Atkins, AC Zannettino |
Bone | 2004 |
Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties
JS Day, M Ding, P Bednarz, JC van der Linden, T Mashiba, T Hirano, CC Johnston, DB Burr, I Hvid, DR Sumner, H Weinans |
Journal of Orthopaedic Research | 2004 |
The degree of mineralization is a determinant of bone strength: a study on human calcanei
H Follet, G Boivin, C Rumelhart, PJ Meunier |
Bone | 2004 |
Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition
M Chaplet, C Detry, C Deroanne, LW Fisher, V Castronovo, A Bellahcéne |
Biochemical Journal | 2004 |
Strontium ranelate: A novel mode of action leading to renewed bone quality
P Ammann |
Osteoporosis International | 2004 |
Peri-implant Bone Remodeling after Total Hip Replacement Combined with Systemic Alendronate Treatment: A Finite Element Analysis
B Peter, N Ramaniraka, LR Rakotomanana, PY Zambelli, DP Pioletti |
Computer Methods in Biomechanics and Biomedical Engineering | 2004 |
Is bone mineral density predictive of fracture risk reduction?
CA Cefalu |
Current Medical Research and Opinion | 2004 |
The effect of alendronate sodium on spinal fusion: a rabbit model
RA Lehman, TR Kuklo, BA Freedman, JR Cowart, MG Mense, KD Riew |
The Spine Journal | 2004 |
Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis
J Iwamoto, T Takeda, Y Sato, M Uzawa |
Clinical Rheumatology | 2004 |
Suppressed Bone Turnover by Long-Term Bisphosphonate Treatment Accumulates Microdamage but Maintains Intrinsic Material Properties in Cortical Bone of Dog Rib
S Komatsubara, S Mori, T Mashiba, J Li, K Nonaka, Y Kaji, T Akiyama, K Miyamoto, Y Cao, J Kawanishi, H Norimatsu |
Journal of Bone and Mineral Research | 2004 |
Differential Effects of Teriparatide on BMD After Treatment With Raloxifene or Alendronate
B Ettinger, SJ Martin, G Crans, I Pavo |
Journal of Bone and Mineral Research | 2004 |
Teriparatide [PTH(1-34)] Strengthens the Proximal Femur of Ovariectomized Nonhuman Primates Despite Increasing Porosity
M Sato, M Westmore, YL Ma, A Schmidt, QQ Zeng, EV Glass, J Vahle, R Brommage, CP Jerome, CH Turner |
Journal of Bone and Mineral Research | 2004 |
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
PJ Meunier, C Roux, E Seeman, S Ortolani, JE Badurski, TD Spector, J Cannata, A Balogh, EM Lemmel, S Pors-Nielsen, R Rizzoli, HK Genant, JY Reginster |
New England Journal of Medicine | 2004 |
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
HG Bone, D Hosking, JP Devogelaer, JR Tucci, RD Emkey, RP Tonino, JA Rodriguez-Portales, RW Downs, J Gupta, AC Santora, UA Liberman |
New England Journal of Medicine | 2004 |
The Xmas present for women’s health: a strike to osteoporosis prevention
M Gambacciani, AR Genazzani |
Maturitas | 2004 |
Can the increase of bone mineral density following bisphosphonates treatments be explained by biomechanical considerations?
DP Pioletti, LR Rakotomanana |
Clinical Biomechanics | 2004 |
Bisphosphonate therapy in children with osteogenesis imperfecta
F Rauch |
BoneKEy-Osteovision | 2004 |
Bone microarchitecture as an important determinant of bone strength
LD Carbonare, S Giannini |
Journal of Endocrinological Investigation | 2004 |
Encyclopedia of Endocrine Diseases
J Borén, O Wiklund |
Encyclopedia of Endocrine Diseases | 2004 |
High-dose Alendronate Uncouples Osteoclast and Osteoblast Function: A Study in a Rat Spine Pseudarthrosis Model
AA Sama, SN Khan, ER Myers, RC Huang, FP Cammisa, HS Sandhu, JM Lane |
Clinical Orthopaedics and Related Research® | 2004 |
Osteoporose-Manual
R Bartl, C Bartl |
2004 | |
Fifteen Years of Clinical Experience with Hydroxyapatite Coatings in Joint Arthroplasty
JA Epinette, MT Manley |
2004 | |
Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study
RR Recker, RS Weinstein, CH Chesnut, RC Schimmer, P Mahoney, C Hughes, B Bonvoisin, PJ Meunier |
Osteoporosis International | 2004 |
RETRACTED ARTICLE: Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis
J Iwamoto, T Takeda, Y Sato, M Uzawa |
Clinical Rheumatology | 2004 |
Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism
F Rauch, H Plotkin, R Travers, L Zeitlin, FH Glorieux |
The Journal of clinical endocrinology and metabolism | 2003 |
The role of bisphosphonates in diseases of childhood
T Srivastava, US Alon |
European Journal of Pediatrics | 2003 |
Making decisions about hormone replacement therapy: bisphosphonates should not be recommended for women aged 50
SM Ott |
BMJ (Clinical research ed.) | 2003 |
Use of highly potent bisphosphonates in the treatment of osteoporosis
M McClung |
Current Osteoporosis Reports | 2003 |
Zoledronic acid: an advance in tumour bone disease therapy and a new hope for osteoporosis
JJ Body |
Expert Opinion on Pharmacotherapy | 2003 |
Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis
PD Miller |
Expert Opinion on Pharmacotherapy | 2003 |
Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog Vertebra
S Komatsubara, S Mori, T Mashiba, M Ito, J Li, Y Kaji, T Akiyama, K Miyamoto, Y Cao, J Kawanishi, H Norimatsu |
Journal of Bone and Mineral Research | 2003 |
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal
YZ Bagger, LB Tankó, P Alexandersen, P Ravn, C Christiansen |
Bone | 2003 |
La paradójica acción, a nivel óseo, de los bisfosfonatos
HR Lenza |
Revista Clínica Española | 2003 |
Injectable bisphosphonates in the treatment of postmenopausal osteoporosis
L Sartori, S Adami, P Filipponi, G Crepaldi |
Aging clinical and experimental research | 2003 |
Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease
Nathalie Franchimont, Ernesto Canalis |
Autoimmunity Reviews | 2003 |
Les facteurs déterminants de la résistance mécanique osseuse
P Ammann |
Thérapie | 2003 |
Bone strength and its determinants
P Ammann, R Rizzoli |
Osteoporosis International | 2003 |
Handbook of Histology Methods for Bone and Cartilage
YH An, KL Martin |
2003 | |
New Bone Formation with Teriparatide [Human Parathyroid Hormone-(1–34)] Is Not Retarded by Long-Term Pretreatment with Alendronate, Estrogen, or Raloxifene in Ovariectomized Rats
YL Ma, HU Bryant, Q Zeng, A Schmidt, J Hoover, HW Cole, W Yao, WS Jee, M Sato |
Endocrinology | 2003 |
Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model
J Kumer, W Yao, T Breunig, T Wronski, G Modin, JH Kinney, NE Lane |
Osteoporosis International | 2003 |
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis
N Morabito, A Gaudio, A Lasco, C Vergara, F Tallarida, G Crisafulli, A Trifiletti, M Cincotta, MA Pizzoleo, N Frisina |
Osteoporosis International | 2003 |
The Effects of Intravenous Pamidronate on the Developing Skeleton: A Histomorphometric Study in Children and Adolescents with Osteogenesis Imperfecta
Frank Rauch, Rose Travers, Horacio Plotkin, Francis H. Glorieux |
Journal of Clinical Investigation | 2002 |
Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis
EF Eriksen, F Melsen, E Sod, I Barton, A Chines |
Bone | 2002 |
Synchrotron Radiation Microtomography Allows the Analysis of Three-Dimensional Microarchitecture and Degree of Mineralization of Human Iliac Crest Biopsy Specimens: Effects of Etidronate Treatment
S Nuzzo, MH Lafage-Proust, E Martin-Badosa, G Boivin, T Thomas, C Alexandre, F Peyrin |
Journal of Bone and Mineral Research | 2002 |
Pharmacological and clinical properties of alendronate sodium hydrate
T OHTA, S KOMATSU, N TOKUTAKE |
Folia Pharmacologica Japonica | 2002 |
Bisphosphonates and Periodontics: Potential Applications for Regulation of Bone Mass in the Periodontium and Other Therapeutic/ Diagnostic Uses
HC Tenenbaum, A Shelemay, B Girard, R Zohar, PC Fritz |
Journal of Periodontology | 2002 |
Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis
PD Delmas |
Bone | 2002 |
Two-Year Results of Once-Weekly Administration of Alendronate 70 mg for the Treatment of Postmenopausal Osteoporosis
R Rizzoli |
Journal of Bone and Mineral Research | 2002 |
Long-Term Predictions of the Therapeutic Equivalence of Daily and Less Than Daily Alendronate Dosing
CJ Hernandez, GS Beaupré, R Marcus, DR Carter |
Journal of Bone and Mineral Research | 2002 |
Raloxifene, Estrogen, and Alendronate Affect the Processes of Fracture Repair Differently in Ovariectomized Rats
Y Cao, S Mori, T Mashiba, MS Westmore, L Ma, M Sato, T Akiyama, L Shi, S Komatsubara, K Miyamoto, H Norimatsu |
Journal of Bone and Mineral Research | 2002 |
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats
S Bourrin, P Ammann, JP Bonjour, R Rizzoli |
Bone | 2002 |
Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety
IR Reid |
Expert Opinion on Drug Safety | 2002 |
Effects of a single infusion of pamidronate prior to liver transplantation: a bone histomorphometric study
S Vedi, M Ninkovic, NJ Garrahan, GJ Alexander, JE Compston |
Transplant International | 2002 |
Prevention of Bone Loss in Ovariectomized Rats by Combined Treatment With Risedronate and 1α,25-Dihydroxyvitamin D3
RG Erben, L Mosekilde, JS Thomsen, K Weber, K Stahr, A Leyshon, SY Smith, R Phipps |
Journal of Bone and Mineral Research | 2002 |
Bone Histomorphometric and Biochemical Marker Results of a 2-Year Placebo-Controlled Trial of Raloxifene in Postmenopausal Women
SM Ott, A Oleksik, Y Lu, K Harper, P Lips |
Journal of Bone and Mineral Research | 2002 |
Ostéopathies et enthésopathies d’origine médicamenteuse
RM Javier, JL Kuntz |
Revue du Rhumatisme | 2002 |
Osteopenias y osteoporosis
HR Lenza |
Medicine - Programa de Formación Médica Continuada Acreditado | 2002 |
Changes in Bone Remodeling Rate Influence the Degree of Mineralization of Bone
G Boivin, PJ Meunier |
Connective Tissue Research | 2002 |
Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report
J Iwamoto, T Takeda |
Journal of Orthopaedic Science | 2002 |
Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis: A Comparative Review
RB Kherani, A Papaioannou, JD Adachi |
Drug Safety | 2002 |
Alendronate Increases Bone Mass and Reduces Bone Markers in Postmenopausal African-American Women
NH Bell, JP Bilezikian, HG Bone, A Kaur, A Maragoto, AC Santora |
The Journal of clinical endocrinology and metabolism | 2002 |
Effect of Estrogen Replacement Plus Low-Dose Alendronate Treatment on Bone Density in Surgically Postmenopausal Women with Osteoporosis
S Palomba, F Orio, A Colao, C di Carlo, T Sena, G Lombardi, F Zullo, P Mastrantonio |
The Journal of clinical endocrinology and metabolism | 2002 |
II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women
A Cranney, G Wells, A Willan, L Griffith, N Zytaruk, V Robinson, D Black, J Adachi, B Shea, P Tugwell, G Guyatt |
Endocrine reviews | 2002 |
A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis
JJ Body, GA Gaich, WH Scheele, PM Kulkarni, PD Miller, A Peretz, RK Dore, R Correa-Rotter, A Papaioannou, DC Cumming, AB Hodsman |
The Journal of clinical endocrinology and metabolism | 2002 |
Perspective: Reconsidering the Effects of Antiresorptive Therapies in Reducing Osteoporotic Fracture
CH Chesnut, CJ Rosen |
Journal of Bone and Mineral Research | 2001 |
Statins and bones
MH Moghadasian, JJ Frohlich |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2001 |
Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women
P Roschger, S Rinnerthaler, J Yates, GA Rodan, P Fratzl, K Klaushofer |
Bone | 2001 |
The role of bisphosphonates as adjuvant therapy for breast cancer
JR Gralow |
Current Oncology Reports | 2001 |
Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate
P Ballanti, G Coen, S Mazzaferro, F Taggi, M Giustini, S Calabria, M Ferrannini, E Bonucci |
Histopathology | 2001 |
Incadronate and Etidronate Accelerate Phosphate-Primed Mineralization of MC4 Cells via ERK1/2-Cbfal Signaling Pathway in a Ras-Independent Manner: Further Involvement of Mevalonate-Pathway Blocade for Incadronate
T Fujita, N Izumo, R Fukuyama, T Meguro, C Yasutomi, H Nakamuta, M Koida |
The Japanese Journal of Pharmacology | 2001 |
How many patients are needed? Variation and design considerations in bone histomorphometry
EM Hauge, L Mosekilde, F Melsen, M Frydenberg |
Bone | 2001 |
Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles
T Mashiba, CH Turner, T Hirano, MR Forwood, CC Johnston, DB Burr |
Bone | 2001 |
A theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment
CJ Hernandez, GS Beaupré, R Marcus, DR Carter |
Bone | 2001 |
The influence of bone volume fraction and ash fraction on bone strength and modulus
CJ Hernandez, GS Beaupré, TS Keller, DR Carter |
Bone | 2001 |
Alendronate: An Update of its Use in Osteoporosis
M Sharpe, S Noble, CM Spencer |
Drugs | 2001 |
Primary and Secondary Preventive Nutrition
A Bendich, RJ Deckelbaum |
2001 | |
Noninvasive Assessment of Trabecular Bone Architecture and the Competence of Bone
S Majumdar, BK Bay |
2001 | |
Fragility Fractures in Dialysis and Transplant Patients. Is it Osteoporosis, and how should it be Treated?
AB Hodsman |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 2001 |
Bone Structure in Patients with Low Bone Mineral Density With or Without Vertebral Fractures
A Oleksik, SM Ott, S Vedi, N Bravenboer, J Compston, P Lips |
Journal of Bone and Mineral Research | 2000 |
How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?
PD Delmas |
Bone | 2000 |
Concentration of Bisphosphonate (Incadronate) in Callus Area and Its Effects on Fracture Healing in Rats
J Li, S Mori, Y Kaji, J Kawanishi, T Akiyama, H Norimatsu |
Journal of Bone and Mineral Research | 2000 |
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
GY Boivin, PM Chavassieux, AC Santora, J Yates, PJ Meunier |
Bone | 2000 |
Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib
T Mashiba, T Hirano, CH Turner, MR Forwood, CC Johnston, DB Burr |
Journal of Bone and Mineral Research | 2000 |
Effects of Alendronate on Bone Quality and Remodeling in Glucocorticoid-Induced Osteoporosis: A Histomorphometric Analysis of Transiliac Biopsies
PM Chavassieux, ME Arlot, JP Roux, N Portero, A Daifotis, AJ Yates, NA Hamdy, MP Malice, D Freedholm, PJ Meunier |
Journal of Bone and Mineral Research | 2000 |
Southwestern Internal Medicine Conference
MA Vazquez |
The American Journal of the Medical Sciences | 2000 |
Bone Matters: Are Density Increases Necessary to Reduce Fracture Risk?
KG Faulkner |
Journal of Bone and Mineral Research | 2000 |
Bisphosphonates in Bone Disease
H Fleisch |
Bisphosphonates in Bone Disease | 2000 |
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group
CH 3rd, S Silverman, K Andriano, H Genant, A Gimona, S Harris, D Kiel, M LeBoff, M Maricic, P Miller, C Moniz, M Peacock, P Richardson, N Watts, D Baylink |
The American Journal of Medicine | 2000 |
Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis
T Schnitzer, HG Bone, G Crepaldi, S Adami, M McClung, D Kiel, D Felsenberg, RR Recker, RP Tonino, C Roux, A Pinchera, AJ Foldes, SL Greenspan, MA Levine, R Emkey, AC Santora, A Kaur, DE Thompson, J Yates, JJ Orloff |
Aging clinical and experimental research | 2000 |
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1
SC Manolagas |
Endocrine reviews | 2000 |
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
J Pfeilschifter, IJ Diel |
Journal of Clinical Oncology | 2000 |
The Treatment of Osteoporosis: Antiresorptive Therapy
PD Miller |
Clinics in Laboratory Medicine | 2000 |
Management of Fractures in Severely Osteoporotic Bone
K Obrant |
2000 | |
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
LI Plotkin, RS Weinstein, AM Parfitt, PK Roberson, SC Manolagas, T Bellido |
Journal of Clinical Investigation | 1999 |
Bisphosphonates: from the laboratory to the clinic and back again
RG Russell, MJ Rogers |
Bone | 1999 |
Early Estrogen Replacement Therapy Reverses the Rapid Loss of Trabecular Bone Volume and Prevents Further Deterioration of Connectivity in the Rat
NE Lane, D Haupt, DB Kimmel, G Modin, JH Kinney |
Journal of Bone and Mineral Research | 1999 |
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach
E Hauge, L Mosekilde, F Melsen |
Bone | 1999 |
Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral Properties
MC Monier-Faugere, Z Geng, EP Paschalis, Q Qi, I Arnala, F Bauss, AL Boskey, HH Malluche |
Journal of Bone and Mineral Research | 1999 |
Changing perceptions in osteoporosis
TJ Wilkin |
BMJ (Clinical research ed.) | 1999 |
The pharmacology of bisphosphonates and new insights into their mechanisms of action
RG Russell, MJ Rogers, JC Frith, SP Luckman, FP Coxon, HL Benford, PI Croucher, C Shipman, HA Fleisch |
Journal of Bone and Mineral Research | 1999 |
The Bisphosphonate Odyssey. A Journey from Chemistry to the Clinic
R Graham, G Russell |
Phosphorus Sulfur and Silicon and the Related Elements | 1999 |
Treatment Considerations in the Management of Age-Related Osteoporosis
NM Kaplan, BF Palmer, CD Rubin |
The American Journal of the Medical Sciences | 1999 |
Morphometric Evidence That YM175, a Bisphosphonate, Reduces Trabecular Bone Resorption in Ovariectomized Dogs With Dietary Calcium Restriction
N Ouchi, H Nishikawa, H Motoie, H Shikama |
The Japanese Journal of Pharmacology | 1999 |
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis
MC Hochberg, PD Ross, D Black, SR Cummings, HK Genant, MC Nevitt, E Barrett-Connor, T Musliner, D Thompson |
Arthritis & Rheumatism | 1999 |
Pharmacological Management of Osteoporosis in Postmenopausal Women: A Comparative Review
IR Reid |
Drugs & Aging | 1999 |
Bisphosphonates
JJ Body |
European Journal of Cancer | 1998 |
Bisphosphonates and osteoporosis treatment in Italy
C Gennari, JY Reginster |
Aging clinical and experimental research | 1998 |
Emerging Therapies for the Prevention or Treatment of Postmenopausal Osteoporosis
M Sato, TA Grese, JA Dodge, HU Bryant, CH Turner |
Journal of Medicinal Chemistry | 1998 |
A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis:
JP Devogelaer |
Drug Safety | 1998 |
Osteoporosis
DL Glaser, FS Kaplan |
Spine | 1997 |
Bone mineral density reflects bone mass but also the degree of mineralization of bone: Therapeutic implications
PJ Meunier, G Boivin |
Bone | 1997 |